ID   E2AK1_HUMAN             Reviewed;         630 AA.
AC   Q9BQI3; Q8NBW3; Q9HC02; Q9NYE0; Q9P0V6; Q9P1J5; Q9P2H8; Q9UHG4;
DT   11-JUL-2001, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2003, sequence version 2.
DT   05-OCT-2010, entry version 106.
DE   RecName: Full=Eukaryotic translation initiation factor 2-alpha kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=Heme-controlled repressor;
DE            Short=HCR;
DE   AltName: Full=Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase;
DE   AltName: Full=Heme-regulated inhibitor;
DE   AltName: Full=Hemin-sensitive initiation factor 2-alpha kinase;
GN   Name=EIF2AK1; Synonyms=HRI, KIAA1369; ORFNames=PRO1362;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hair follicle dermal papilla;
RX   MEDLINE=20550853; PubMed=11101152; DOI=10.1007/s100590000016;
RA   Hwang S.-Y., Kim M.-K., Kim J.-C.;
RT   "Cloning of hHRI, human heme-regulated eukaryotic initiation factor
RT   2alpha kinase: down-regulated in epithelial ovarian cancers.";
RL   Mol. Cells 10:584-591(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RA   Cannon G., Naik S.M., Boss J.M., Caughman S.W.;
RT   "Cloning of the human heme-regulated eukaryotic initiation factor 2-
RT   alpha kinase from TNF-alpha stimulated dermal microvascular
RT   endothelial cells.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   MEDLINE=20181126; PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hypothalamus;
RX   MEDLINE=20402571; PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   MEDLINE=21154917; PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   MEDLINE=22279635; PubMed=12391722; DOI=10.1080/10425170290023428;
RA   Omasa T., Chen Y.-G., Mantalaris A., Tsai Y.C., Wu J.H.;
RT   "Molecular cloning and sequencing of the human heme-regulated
RT   eukaryotic initiation factor 2 alpha (eIF-2 alpha) kinase from bone
RT   marrow culture.";
RL   DNA Seq. 13:133-137(2002).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-558.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 450-630, AND VARIANT
RP   ARG-558.
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Wei H., Zhou G., Ouyang S., Luo L., Bi J.,
RA   Liu M., He F.;
RT   "Functional prediction of the coding sequences of 121 new genes
RT   deduced by analysis of cDNA clones from human fetal liver.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   INTERACTION WITH CDC37 AND THE HSP90 COMPLEX.
RX   MEDLINE=20576356; PubMed=11036079; DOI=10.1074/jbc.M007583200;
RA   Shao J., Grammatikakis N., Scroggins B.T., Uma S., Huang W.,
RA   Chen J.-J., Hartson S.D., Matts R.L.;
RT   "Hsp90 regulates p50(cdc37) function during the biogenesis of the
RT   active conformation of the heme-regulated eIF2 alpha kinase.";
RL   J. Biol. Chem. 276:206-214(2001).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275; SER-276; SER-277
RP   AND SER-278, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-258 AND SER-295,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-117; THR-132; LYS-134; SER-139;
RP   HIS-145; SER-202; LEU-292; HIS-319 AND ARG-558.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Mediates down-regulation of protein synthesis in
CC       response to various stress conditions by the phosphorylation of
CC       EIF2S1 at 'Ser-48' and 'Ser-51'. Protein synthesis is inhibited at
CC       the level of initiation (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Hemin inactivates EIF2AK1 by promoting the
CC       formation of a disulfide-linked homodimer. Binding of nitric oxide
CC       (NO) to the heme iron in the N-terminal heme-binding domain
CC       activates the kinase activity, while binding of carbon monoxide
CC       (CO) suppresses kinase activity (By similarity).
CC   -!- SUBUNIT: Synthesized in an inactive form that binds to the N-
CC       terminal domain of CDC37. Has to be associated with a multiprotein
CC       complex containing Hsp90, CDC37 and PPP5C for maturation and
CC       activation by autophosphorylation. The phosphatase PPP5C modulates
CC       this activation. Homodimer; non-covalently bound in the absence of
CC       hemin. Converted to an inactive disulfide linked homodimer in the
CC       presence of hemin (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BQI3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BQI3-2; Sequence=VSP_007589;
CC   -!- TISSUE SPECIFICITY: Detected in heart, brain, placenta, lung,
CC       liver, skeletal muscle, pancreas, kidney, spleen, muscle and
CC       stomach.
CC   -!- PTM: Activated by autophosphorylation; phosphorylated
CC       predominantly on serine and threonine residues, but also on
CC       tyrosine residues (By similarity).
CC   -!- MISCELLANEOUS: Can bind 2 molecules of heme per polypeptide chain
CC       (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. GCN2 subfamily.
CC   -!- SIMILARITY: Contains 2 HRM (heme regulatory motif) repeats.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF71057.1; Type=Erroneous initiation;
CC       Sequence=BAA92607.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF255050; AAF70289.1; -; mRNA.
DR   EMBL; AF181071; AAF18391.1; -; mRNA.
DR   EMBL; AB037790; BAA92607.1; ALT_INIT; mRNA.
DR   EMBL; AF183414; AAG09683.1; -; mRNA.
DR   EMBL; AL136563; CAB66498.1; -; mRNA.
DR   EMBL; AF147094; AAF66736.1; -; mRNA.
DR   EMBL; AK075192; BAC11461.1; -; mRNA.
DR   EMBL; AL834494; CAD39152.1; -; mRNA.
DR   EMBL; BC006524; AAH06524.1; -; mRNA.
DR   EMBL; AF116634; AAF71057.1; ALT_INIT; mRNA.
DR   IPI; IPI00328149; -.
DR   IPI; IPI00328150; -.
DR   RefSeq; NP_001127807.1; -.
DR   RefSeq; NP_055228.2; -.
DR   UniGene; Hs.724455; -.
DR   ProteinModelPortal; Q9BQI3; -.
DR   SMR; Q9BQI3; 157-587.
DR   IntAct; Q9BQI3; 6.
DR   STRING; Q9BQI3; -.
DR   PhosphoSite; Q9BQI3; -.
DR   PRIDE; Q9BQI3; -.
DR   Ensembl; ENST00000199389; ENSP00000199389; ENSG00000086232.
DR   GeneID; 27102; -.
DR   KEGG; hsa:27102; -.
DR   NMPDR; fig|9606.3.peg.28227; -.
DR   UCSC; uc003spp.1; human.
DR   CTD; 27102; -.
DR   GeneCards; GC07M006061; -.
DR   H-InvDB; HIX0006461; -.
DR   HGNC; HGNC:24921; EIF2AK1.
DR   HPA; CAB022082; -.
DR   HPA; HPA016496; -.
DR   PharmGKB; PA134919097; -.
DR   HOVERGEN; HBG051429; -.
DR   InParanoid; Q9BQI3; -.
DR   OMA; RECVDES; -.
DR   OrthoDB; EOG9PG8KT; -.
DR   PhylomeDB; Q9BQI3; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 49763; -.
DR   ArrayExpress; Q9BQI3; -.
DR   Bgee; Q9BQI3; -.
DR   CleanEx; HS_EIF2AK1; -.
DR   Genevestigator; Q9BQI3; -.
DR   GermOnline; ENSG00000086232; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004694; F:eukaryotic translation initiation factor 2a...; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0046986; P:negative regulation of hemoglobin biosynthe...; ISS:UniProtKB.
DR   GO; GO:0045993; P:negative regulation of translational initia...; NAS:UniProtKB.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0009605; P:response to external stimulus; IEP:UniProtKB.
DR   GO; GO:0006950; P:response to stress; IEP:UniProtKB.
DR   InterPro; IPR015516; Haem-reg_EIF2A_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   PANTHER; PTHR11042:SF16; Hm-Reg_EIF2A_Kin; 1.
DR   Pfam; PF00069; Pkinase; 2.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Disulfide bond;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Protein synthesis inhibitor; Repeat; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    630       Eukaryotic translation initiation factor
FT                                2-alpha kinase 1.
FT                                /FTId=PRO_0000085941.
FT   DOMAIN      167    583       Protein kinase.
FT   REPEAT      410    415       HRM 1.
FT   REPEAT      552    557       HRM 2.
FT   NP_BIND     173    181       ATP (By similarity).
FT   ACT_SITE    442    442       Proton acceptor (By similarity).
FT   BINDING     196    196       ATP (By similarity).
FT   MOD_RES       6      6       Phosphoserine.
FT   MOD_RES     258    258       Phosphoserine.
FT   MOD_RES     275    275       Phosphoserine.
FT   MOD_RES     276    276       Phosphoserine.
FT   MOD_RES     277    277       Phosphoserine.
FT   MOD_RES     278    278       Phosphoserine.
FT   MOD_RES     295    295       Phosphoserine.
FT   MOD_RES     488    488       Phosphothreonine; by autocatalysis (By
FT                                similarity).
FT   VAR_SEQ     244    244       Missing (in isoform 2).
FT                                /FTId=VSP_007589.
FT   VARIANT     117    117       R -> T (in dbSNP:rs34889754).
FT                                /FTId=VAR_040466.
FT   VARIANT     132    132       K -> T (in dbSNP:rs34851195).
FT                                /FTId=VAR_040467.
FT   VARIANT     134    134       R -> K (in dbSNP:rs55744865).
FT                                /FTId=VAR_040468.
FT   VARIANT     139    139       P -> S (in dbSNP:rs55963745).
FT                                /FTId=VAR_040469.
FT   VARIANT     145    145       R -> H (in dbSNP:rs55971369).
FT                                /FTId=VAR_040470.
FT   VARIANT     202    202       G -> S (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_040471.
FT   VARIANT     292    292       F -> L (in dbSNP:rs55982710).
FT                                /FTId=VAR_040472.
FT   VARIANT     319    319       L -> H (in dbSNP:rs34909691).
FT                                /FTId=VAR_040473.
FT   VARIANT     558    558       K -> R (in dbSNP:rs2640).
FT                                /FTId=VAR_015732.
FT   CONFLICT      2      2       Q -> L (in Ref. 2; AAF18391).
FT   CONFLICT     24     32       PPAIDFPAE -> RRHRLSRR (in Ref. 1;
FT                                AAF70289).
FT   CONFLICT    137    137       Q -> R (in Ref. 1; AAF70289).
FT   CONFLICT    171    171       A -> V (in Ref. 2; AAF18391).
FT   CONFLICT    206    206       T -> P (in Ref. 6; AAF66736).
SQ   SEQUENCE   630 AA;  71106 MW;  D63021651806620B CRC64;
     MQGGNSGVRK REEEGDGAGA VAAPPAIDFP AEGPDPEYDE SDVPAEIQVL KEPLQQPTFP
     FAVANQLLLV SLLEHLSHVH EPNPLRSRQV FKLLCQTFIK MGLLSSFTCS DEFSSLRLHH
     NRAITHLMRS AKERVRQDPC EDISRIQKIR SREVALEAQT SRYLNEFEEL AILGKGGYGR
     VYKVRNKLDG QYYAIKKILI KGATKTVCMK VLREVKVLAG LQHPNIVGYH TAWIEHVHVI
     QPRADRAAIE LPSLEVLSDQ EEDREQCGVK NDESSSSSII FAEPTPEKEK RFGESDTENQ
     NNKSVKYTTN LVIRESGELE STLELQENGL AGLSASSIVE QQLPLRRNSH LEESFTSTEE
     SSEENVNFLG QTEAQYHLML HIQMQLCELS LWDWIVERNK RGREYVDESA CPYVMANVAT
     KIFQELVEGV FYIHNMGIVH RDLKPRNIFL HGPDQQVKIG DFGLACTDIL QKNTDWTNRN
     GKRTPTHTSR VGTCLYASPE QLEGSEYDAK SDMYSLGVVL LELFQPFGTE MERAEVLTGL
     RTGQLPESLR KRCPVQAKYI QHLTRRNSSQ RPSAIQLLQS ELFQNSGNVN LTLQMKIIEQ
     EKEIAELKKQ LNLLSQDKGV RDDGKDGGVG
//
